Skip to main content
Omar Alhalabi, MD, Oncology, Houston, TX

OmarAlhalabiMD

Oncology Houston, TX

Assistant Professor

Dr. Alhalabi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Alhalabi's full profile

Already have an account?

  • Office

    1515 Holcombe Blvd
    Houston, TX 77030
    Phone+1 713-792-6161

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
  • Corewell Health East Beaumont (Royal Oak)
    Corewell Health East Beaumont (Royal Oak)Residency, Internal Medicine, 2014 - 2017
  • Damascus University Faculty of Medicine
    Damascus University Faculty of MedicineClass of 2013, MD

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • TN State Medical License
    TN State Medical License 2023 - 2027
  • MI State Medical License
    MI State Medical License 2016 - 2026
  • WA State Medical License
    WA State Medical License 2023 - 2026
  • AL State Medical License
    AL State Medical License 2023 - 2025
  • AZ State Medical License
    AZ State Medical License 2023 - 2025
  • GA State Medical License
    GA State Medical License 2023 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Correlation of methylthioadenosine phosphorylase (MTAP) loss with response to anti-folate therapy in urothelial bladder carcinoma (UBC). 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • MD Anderson Research Highlights for February 26, 2025
    MD Anderson Research Highlights for February 26, 2025February 26th, 2025
  • MD Anderson Unveils Groundbreaking Research Breakthroughs – February 26, 2025
    MD Anderson Unveils Groundbreaking Research Breakthroughs – February 26, 2025February 26th, 2025
  • Metastatic Prostate Cancer: Investigators Ponder New Path to Improve Survival
    Metastatic Prostate Cancer: Investigators Ponder New Path to Improve SurvivalSeptember 30th, 2022
  • Join now to see all

Professional Memberships